In previous studies, Staphylococcus aureus has been shown to bind fibronectin (P. Kuusela, Nature (London) 276: [718][719][720] 1978), an interaction that may be important in bacterial attachment and opsonization. Recently some strains of streptococci of serological groups A, C, and G were also found to bind fibronectin. The binding to one selected strain of Streptococcus pyogenes has been characterized here. The binding of ['251]fibronectin to streptococcal cells resembles that to staphylococcal cells and was found to be time dependent, functionally irreversible, and specific in the sense that unlabeled proteins other than fibronectin did not block binding. Bacteria incubated with proteases largely lost their ability to bind fibronectin, and material released from the streptococci by a brief trypsin digestion contained active fibronectin receptors. This material inhibited the binding of [I25]fibronectin to the streptococci. The inhibitory activity was adsorbed on a column of fibronectin-Sepharose but not on a column of unsubstituted Sepharose 4B or egg albumin Sepharose. The receptor appeared to be a protein nature since the inhibitory activity of the trypsinate was destroyed by papain and was not adsorbed on a column containing monoclonal antibodies directed against lipoteichoic acid bound to protein A-Sepharose. Binding sites in fibronectin for streptococci and staphylococci, respectively, were localized by analyzing the ability of isolated fragments to inhibit [125I]fibronectin binding to bacteria and by adsorbing I251-labeled tryptic fragments with staphylococcal and streptococcal cells. Both species of bacteria appeared to preferentially bind a fragment (Mr = -25,000) originating from the N-terminal region of the protein. In addition, streptococci also bound a slightly smaller fragment (Mr = -23,000). Fibronectin receptors solubilized from either streptococci or staphylococci inhibited the binding of fibronectin to both species of bacteria.
In previous studies, Staphylococcus aureus has been shown to bind fibronectin (P. Kuusela, Nature (London) 276: [718] [719] [720] 1978) , an interaction that may be important in bacterial attachment and opsonization. Recently some strains of streptococci of serological groups A, C, and G were also found to bind fibronectin. The binding to one selected strain of Streptococcus pyogenes has been characterized here. The binding of ['251] fibronectin to streptococcal cells resembles that to staphylococcal cells and was found to be time dependent, functionally irreversible, and specific in the sense that unlabeled proteins other than fibronectin did not block binding. Bacteria incubated with proteases largely lost their ability to bind fibronectin, and material released from the streptococci by a brief trypsin digestion contained active fibronectin receptors. This material inhibited the binding of [I25] fibronectin to the streptococci. The inhibitory activity was adsorbed on a column of fibronectin-Sepharose but not on a column of unsubstituted Sepharose 4B or egg albumin Sepharose. The receptor appeared to be a protein nature since the inhibitory activity of the trypsinate was destroyed by papain and was not adsorbed on a column containing monoclonal antibodies directed against lipoteichoic acid bound to protein A-Sepharose. Binding sites in fibronectin for streptococci and staphylococci, respectively, were localized by analyzing the ability of isolated fragments to inhibit [125I]fibronectin binding to bacteria and by adsorbing I251-labeled tryptic fragments with staphylococcal and streptococcal cells. Both species of bacteria appeared to preferentially bind a fragment (Mr = -25,000) originating from the N-terminal region of the protein. In addition, streptococci also bound a slightly smaller fragment (Mr = -23,000). Fibronectin receptors solubilized from either streptococci or staphylococci inhibited the binding of fibronectin to both species of bacteria.
Fibronectin is a class of closely related glycoproteins found in connective tissue and in blood plasma (for recent reviews, see references 11 and 14) . The ability of fibronectin to serve as a substrate for the adherence of eucaryotic cells is the most prominent biological activity known for the protein, although fibronectin affects many other cellular reactions, e.g., it may act as an unspecific opsonin mediating the phagocytosis by cultured macrophages of gelatin-coated latex beads (3, 21, 23) . Fibronectin binds to a number of other biological macromolecules, such as collagen, actin, fibrin/fibrinogen, heparin, and related glycosaminoglycans. By studying the binding properties of fibronectin peptides generated by limited proteolysis of the protein, different binding sites have been identified and mapped along the fibronectin molecule (see the reviews cited above and the references therein).
In 1978, Kuusela reported that fibronectin binds to heatkilled and Formalin-fixed Staphylococcus aureus cells (7) , and later Mosher and Proctor located the staphylococcal binding site to a peptide derived from the N-terminal region of the protein (12) . Recent studies in our and other laboratories have confirmed and extended these findings (2, 20, 22) . Some staphylococcal strains contain a fibronectin receptor protein that can be solubilized by treatment with bacteriolytic enzymes (lysostaphin) (15) . Also, many streptococcal strains have been shown to bind fibronectin (1, 16, 19) . In the present communication, the binding of fibronectin to a Streptococcus pyogenes strain is characterized and compared with that between fibronectin and staphylococci. The biological implications of "the fibronectin-bacteria interactions are discussed.
Md.) under constant rotation for 18 h at 37°C. Both strains of bacteria were harvested by centrifugation (800 x g, 20 min, 20°C), resuspended, and washed twice in phosphate-buffered saline (PBS) (0.13 M sodium chloride and 0.02% sodium azide in 10 mM phosphate buffer, pH 7.4). Unless otherwise indicated, bacteria were killed by being heated to 88°C for 20 min. Cells were then suspended in PBS to a cell density of 1010/ml and stored at -20°C. The concentration of bacteria was determined by counting cells in a Petroff-Hausser chamber.
Binding of [1251] fibronectin to bacteria. The method used for quantitating the binding of [125I]fibronectin to bacteria was essentially as described (15) . Bacteria (3 x 10' cells) were incubated with 105 cpm of 125I-labeled fibronectin in 1.2 ml of PBS containing 0.1% bovine serum albumin. The tubes containing the mixtures were incubated end over end at 20°C for 3 h unless otherwise stated. Subsequently, 200 ,ul of the incubation mixture was carefully added to 0.5 ml of PBS layered on top of 3 ml of Percoll in 0.15 M NaCl (density, 1.020 g/ml). The samples were centrifuged at 1,350 x g for 15 min in a swinging bucket rotor. During centrifugation, bacteria sedimented through the gradient medium and formed a visible pellet at the bottom of the tube, whereas the incubation medium remained as a layer on top of the Percoll. The supernatants were aspirated off, and the radioactivity associated with the pellet was measured in a gamma counter (LKB Wallac, Turku, Finland). Radioactivity recovered after centrifugation of mixtures lacking bacteria (usually 200 to 400 cpm) was considered as background and subtracted from values obtained from incubations containing bacteria. Control experiments showed that the presence of bovine serum albumin did not affect the binding of [125I]fibronectin to bacteria. The plastic tubes used in these experiments (Sarstedt, Princeton, N.J.) were preincubated overnight with 1 ml of 0.1% bovine serum albumin in PBS to minimize unspecific binding of proteins and bacteria to the tubes.
Digestion of fibronectin by trypsin. The purified protein (2.6 mg/ml) was incubated with trypsin (1 jxg/ml) in PBS containing no azide at 37°C. After 2 h, soybean trypsin inhibitor (2 ,ug/ml) was added. Fibronectin fragments were 125I-labeled by using the chloramine T method (4).
Incubation of bacteria with proteolytic enzymes. Two hundred milligrams (wet weight) of cells were suspended in 1 ml of PBS containing no azide and digested with trypsin (25 ,ug/ ml) or papain (10 U/ml) at 37°C. At the indicated times, samples were removed from the incubation mixture, and soybean trypsin inhibitor (50 ,ug/ml) was added to the trypsin-digested samples. All samples were heated for 10 min at 90°C. Cells were then pelleted by centrifugation, washed once, and suspended in PBS. Cell wall components of Streptococcus pyogenes 1321, solubilized by a 1-h trypsin digestion (referred to as "trypsinate"), were used in inhibition experiments. Cells of Staphylococcus aureus Cowan 1 were lysed with lysostaphin as described (15) .
Electrophoresis in polyacrylamide gels. Polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate was performed according to the method of Studier (17 Localization of bacterial binding site in fibronectin. To localize the binding sites in fibronectin for streptococcal and staphylococcal cells, we studied the bacterial binding activity of peptides obtained by trypsin digestion of fibronectin. To make sure that all bacterial binding sites are conserved in the generated peptides, intact and fragmented fibronectins were compared as inhibitors of the binding to streptococci and staphylococci, respectively ( Fig. 3A and 3B ). The fragments inhibited the binding to both species of bacteria as well or better than the intact protein. In control experiments, a mixture of trypsin and soybean trypsin inhibitor was not found to affect the binding of [1251] fibronectin to bacteria. Therefore, all bacterial binding sites appear to be retained in the trypsin-generated fragments. [125I] fibronectin. The amount of radioactivity recovered in the tubes in the absence of tested proteins after subtraction of the background value was set as 0% inhibition, and all data are expressed as percentages of the control.
b Immunochemical analysis showed that the fibrinogen preparation contained a small fibronectin contamination (less than 2% of the total proteins) which could be at least partly responsible for the inhibitory activity of the preparation. To identify the fibronectin fragments binding to bacteria, the mixture of peptides was labeled by 1251-iodination. Most but not all of the fibronectin fragments were labeled by this procedure (Fig. 4) . The radiolabeled peptide mixture was then incubated with streptococci or staphylococci. After separation of the cells from the incubation mixture, the fibronectin peptides bound to the bacteria and those peptides remaining in the incubation medium were analyzed by polyacrylamide gel electrophoresis followed by autoradiography (Fig. 5) . Both streptococcal and staphylococcal cells bound one 125I-labeled peptide with an apparent Mr of -27k.
Whereas this peptide appears to be the only fragment associated with staphylococci, streptococci bound an additional peptide (Mr, -23k). These findings indicated that streptococcal cells bound the same peptide that previously had been shown to bind to staphylococci (12) , as well as another somewhat smaller fragment. Since not all fibronectin fragments became 125I-labeled (Fig. 4) , it could not be excluded that the bacteria bound peptides other than those detectable in Fig. 5 .
The relationship between the fibronectin binding sites for staphylococcal and streptococcal cells was further investigated. Fragmented, unlabeled fibronectin was incubated with streptococci and staphylococci, respectively. After the bacteria, along with associated fibronectin fragments, had been removed by centrifugation, the remaining fragments were tested for their ability to inhibit [125I]fibronectin binding to both bacteria. The results show that fragments remaining after adsorption with streptococci were poor inhibitors of
[125I]fibronectin binding to streptococci (Fig. 6A ). These remaining peptides had also largely lost their ability to inhibit the binding of [125I]fibronectin to staphylococci (Fig. 6B) the digested bacteria was tested (Fig. 8) . Both papain and trypsin were shown to destroy the fibronectin binding structures on the bacteria, suggesting that these structures are protein(s). The material released from the bacteria by incubation with trypsin was found to inhibit the binding of
[125I]fibronectin to streptococci, whereas material released by papain had no activity. The inhibitory activity of the trypsinate was not destroyed by heat inactivation (90°C for 10 min) but was abolished when the trypsin-released material was incubated with papain (data not shown). When the trypsinate was passed through a column of fibronectinSepharose, the inhibitory activity was adsorbed (Table 2) . In control experiments, the trypsinate was found to retain its inhibitory activity after passage through columns of egg albumin-Sepharose 4B or unsubstituted Sepharose 4B (Table  2 ). In view of these findings, it seems reasonable to assume that the inhibitory activity in the trypsinate was due to released receptor fragments. In recent reports (1, 16) it was proposed that the fibronectin receptor on streptococci is identical to lipoteichoic acid. In view of the recently demonstrated release of lipoteichoic acid by trypsin digestion of streptococci (9), the possibility was considered that lipoteichoic acid was the active component in the trypsinate. Trypsin-released material was passed through a column of protein A-Sepharose on which had been adsorbed a monoclonal antibody against poly-glycerol-phosphate. The presence of lipoteichoic acid in the trypsinate before and after passage through the immunoadsorbent was estimated by the enzyme-linked immunosorbent assay (Fig.  9) . Lipoteichoic acid was detected in the trypsinate but was removed by passage through the column containing immobilized antibodies. However, the inhibitory activity of the trypsinate was not changed by passing this material through the immunoadsorbent (Table 2 ). These results demonstrate that lipoteichoic acid is not the major fibronectin receptor on Streptococcus pyogenes 1321.
Fibronectin receptors released from streptococcal cells by trypsin digestion and solubilized from staphylococci by incubation with lysostaphin were tried as inhibitors of fibronectin binding to both bacteria. The results of this experiment (Fig. 10) showed that receptor molecules solubilized from streptococci were as efficient as receptors ob- b Ascites fluid (0.4 ml) from a mouse injected with the cloned hybridoma 7 B 11 was mixed with 0.5 ml of 1% ovalbumin in PBS and 0.5 ml of protein A-Sepharose. The mixture was incubated (end over end) for 3 h at 20°C. After the gel was washed with PBS, 1.5 ml of the trypsinate was added, and this mixture was incubated for 2.5 h. The gel containing adsorbed proteins was removed by filtration, and the inhibitory activity of samples (200 ,ul) of the trypsinate before and after adsorption was analyzed. Lipoteichoic acid in material released from streptococci by trypsin digestion before and after immunoadsorption. Streptococcus pyogenes 1321 cells were digested with trypsin as described in the text, and a portion of the released material was adsorbed on a column of anti-poly-glycerol-phosphate antibodies bound to protein A-Sepharose (see Table 2 , footnotes a and b). Samples (200 p.l) of dilutions of the trypsinate before (0) and after (0) immunoadsorption were transfered to a multiwell plate (Linbro E.I.A. microtitration plate) and incubated at 4°C overnight. The wells were washed three times with PBS and incubated with 200 ,ul of 1% bovine serum albumin in PBS for 2 h at 37°C to block remaining protein binding sites on the plastic surface. The wells were washed and incubated at 37°C for 2 h with ascites fluid from a mouse injected with the hybridoma 7 B 11 diluted 100-fold in PBS containing 1% ovalbumin.
After extensive washing, 200 p.l of the second antibody, phosphatase-conjugated goat anti-mouse IgG + IgM (Kirkegaard & Perry Laboratories, Gaithersburg, Md.), was added at a 100-fold dilution, and the incubation was continued for 1.5 h at 37°C. The wells were washed, and the substrate p-nitrophenyl phosphate (Sigma) was added. The absorbance at 405 mm was determined in a Titertek Multiskan (Flow Laboratories, Inc., McLean, Va.).
DISCUSSION
In the present report, the binding of [125I]fibronectin to a strain of Streptococcus pyogenes is characterized. The selected strain originated from a collection of strains of streptococci that were isolated from human infections and that previously had been screened for [125I]fibronectin binding (19) .
Labeled fibronectin bound to the bacteria could not be displaced by subsequent incubation with a large excess of unlabeled fibronectin, demonstrating that the fibronectinbacteria interaction is very strong. The binding of [1251] fibronectin was specific in the sense that it was completely inhibited by the presence of unlabeled fibronectin. Other proteins tested were not as efficient inhibitors of [1251] fibronectin binding to the bacteria, although a significant reduction of the bacteria-bound [1251]fibronectin was observed in the presence of some proteins. These proteins may not necessarily compete with fibronectin for its receptor. It is possible that the observed inhibitory effect of the proteins in Table 1 has sterical grounds. Streptococci have been reported to bind galactose units (T. Wadstrom, unpublished observations), as well as fibrinogen (5) and IgG (6) , and so did the selected strain (data not shown). When these components become bound on the surface of the streptococci, they may partly cover the fibronectin receptors and, for sterical reasons, interfere with the fibronectin receptor interaction. Along this line, egg albumin was found to partially inhibit the binding of fibronectin to streptococci, although solubilized fibronectin receptors showed no affinity for egg albumin Sepharose ( Digestion of streptococci with proteolytic enzymes reduced fibronectin binding to the cells, and the trypsinate inhibited binding of fibronectin to bacteria. In addition to peptides, the trypsinate contained lipoteichoic acid (9) . The latter component could be removed without loss of inhibitory activity. These results demonstrate that lipoteichoic acid is not the major fibronectin receptor on S. pyogenes 1321. The inhibitory activity of the trypsinate was lost after papain digestion, suggesting that the major streptococcal receptor is protein.
Fibronectin receptors solubilized from streptococci or staphylococci inhibited the binding of fibronectin to both species of bacteria. Furthermore, an isolated fibronectin fragment inhibited the binding of intact ['25I]fibronectin to both streptococcal and staphylococcal cells. These findings indicate that both species of bacteria bind to the same structure (or to closely spaced sites) in the fibronectin molecule. The receptors on streptococci and staphylococci differed in susceptibility to proteolytic digestions; the staphylococcal receptor was released by trypsin digestion but in an inactive form (15) , whereas the same treatment released the major streptococcal receptor in an active form. This difference suggests that the primary structures of the major receptor proteins from staphylococci and streptococci may differ.
By analyzing the ability of fibronectin peptides to bind to bacteria or to inhibit the fibronectin-bacteria binding, we located a major bacterial binding site to one peptide (Mr = -25 to 27k) that is derived from the N-terminal region of the molecule. However, streptococci appear to bind an additional peptide of slightly smaller size Mr = -23k). Since this 23k peptide apparently does not bind to staphylococci, it is somewhat surprising that receptors solubilized from the two species of bacteria were equally efficient in inhibiting fibronectin binding to either strain of bacteria. This finding could be explained if two types of fibronectin receptors are present on streptococcal cells; one receptor class that is solubilized by trypsin and binds the 25k peptide and a second class which binds to the smaller 23k peptide and is neither solubilized nor destroyed by trypsin treatment.
A large number of streptococcal and staphylococcal strains express fibronectin receptors, although fibronectin receptor-deficient strains have also been isolated (13, 19, 20) . It is noteworthy that staphylococci and streptococci, which are not genetically closely related, both express distinct surface proteins that have the ability to specifically bind fibronectin. Staphylpcocci and streptococci are also the major causes of bacterial wound infections. In view of these observations, it was proposed that fibronectin binding is advantageous to the bacteria and represents a mechanism of bacterial adherence which enables tissue colonization and development of an infection. In a wounded tissue, fibronectin in the intracellular matrix or fibronectin incorporated into the fibrin clot during blood coagulation may become exposed to bacteria in the environment and serve as a substrate to which bacteria may adhere. It should be noted that some staphylococci and streptococci also often bind to fibrin/ fibrinogen (5, 18) , which may represent a parallel mechanism of bacterial adherence in the wound.
Since fibronectin has been demonstrated to act as an opsonin in some systems, it is tempting to speculate that fibronectin mediates the phagocytosis of bacteria. However, the possible role of fibronectin as an opsonin remains unclear and should be investigated.
